SPOCK2

Across TCGA pan-cancer cohorts, SPOCK2 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated SPOCK2 data layer compared with 25 for mass-spec protein and 3 for mass-spec protein.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher SPOCK2 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated SPOCK2 expression acts as an unfavorable survival marker.

ACC, LUSC, and SKCM are the cancer types where SPOCK2 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.010	0.667	<.001	45	view →
LUSC	OS	Median	II,III,IV	0.011	0.743	<.001	24	view →
SKCM	DFS	Median	All	0.241	0.620	<.001	9	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
LUAD	DFS	Median	All	0.218	0.676	.014	3	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

SPOCK2–ACC (DFS)

Open the ACC breakdown →